Maternal plasma level of endothelin is increased in preeclampsia

https://doi.org/10.1016/0002-9378(91)90317-KGet rights and content

Abstract

Endothelin is a potent vasoconstrictor that is reportedly increased in conditions characterized by endothelial damage. Maternal plasma endothelin levels were compared between 27 women with preeclampsia (23 without and 4 with the hemolysis, elevated liver enzymes, and low platelet count syndrome) and 14 women with normotensive pregnancies. The mean &#x0026;#x0026;#x0026;#x0026;#x0026;#x0026;#x00B1; SEM plasma endothelin values were significantly higher in patients with preeclampsia uncomplicated by the hemolysis, elevated liver enzymes, and low platelet count syndrome (5.48 ± 0.30 fmollml vs 3.86 ± 0.28, p < 0.001). In addition, the preeclamptic group with the hemolysis, elevated liver enzymes, and low platelet count syndrome had significantly higher endothelin levels than those without the syndrome (8.30 ± 1.62 fmollml vs 5.48 ± 0.30, p < 0.05). There was no correlation between plasma endothelin values and either systolic or diastolic blood pressure. We conclude that plasma endothelin levels are significantly increased in women with preeclampsia and particularly in those with the hemolysis, elevated liver enzymes, and low platelet count syndrome, suggesting an association with widespread endothelial damage.

References (14)

There are more references available in the full text version of this article.

Cited by (199)

  • Vascular Endothelial Cell Dysfunction in Preeclampsia

    2021, Chesley’s Hypertensive Disorders in Pregnancy
  • Placentation and Placental Function in Normal and Preeclamptic Pregnancies

    2021, Chesley’s Hypertensive Disorders in Pregnancy
  • Issues in the interpretation of serum endothelin levels in preeclampsia

    2019, Medical Hypotheses
    Citation Excerpt :

    Not long after the discovery of endothelin [1,2], several studies demonstrated that serum levels of this substance were significantly elevated in women who had preeclampsia [3–6].

  • A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease

    2018, Sleep Medicine Reviews
    Citation Excerpt :

    Blood pressure was reduced by administering PlGF to animals in an experimental model of preeclampsia [97]. SFlt-1 and sEng levels are both associated with increased levels of endothelin-1, another potent vasoconstrictor that is elevated in preeclampsia [98]. Antagonism of its downstream receptor (endothelin Type A receptor) has been studied as a means of mitigating the hypertensive effects of these proteins in animal models, and as a potential future therapeutic target in humans [56,99].

  • Mechanisms and Clinical Significance of Endothelial Dysfunction in High-Risk Pregnancies

    2018, Canadian Journal of Cardiology
    Citation Excerpt :

    In addition, serum and urine levels of NO and the stable NO metabolites nitrite and nitrate were significantly reduced in pregnant women with preeclampsia, compared with normotensive pregnant women, although other trials have reported conflicting results.27-30 It has been widely reported that plasma levels of endothelin-1 are significantly elevated in women with preeclampsia, compared with normotensive pregnant women.30,33-35 Women who developed preeclampsia also exhibit increased circulating levels of NTproCNP from 24 weeks' gestation to delivery compared with normotensive pregnant women, potentially representing an adaptive response to an increased vasoconstricted state or reduced clearance, because of renal dysfunction.31,32

  • The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction

    2018, American Journal of Obstetrics and Gynecology
    Citation Excerpt :

    The release of sFlt-1 and soluble endoglin6,7 into the maternal circulation causes endothelial dysfunction, a feature of the placenta-mediated complications of pregnancy and in particular preeclampsia, and an imbalance in vasoactive factors such as endothelin,13 nitric oxide,14 and prostacyclin,15 resulting in reduced vasodilatation and increased vasoconstriction.

View all citing articles on Scopus
View full text